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Background: We tested the hypothesis that dengue haemor-
rhagic fever (DHF) is associated with a TH1-skewed immune 
response as opposed to dengue fever (DF). Methods: We 
estimated intracellular (in T-cells) and serum levels of desig-
nate TH1/TH2 cytokines [interferon-γ  (IFN-γ), interleukin-4 
(IL-4), and tumor necrosis factor-α] and macrophage in-
flammatory protein-1α (MIP-1α) at admission, 48 h, and 
day 5 in 20 adults with dengue (DF=10, DHF=10) and 10 
dengue-naïve healthy controls. Results: At admission, intra-
cellular IFN-γ/IL-4 ratio in CD4＋ T-cells and proportion of 
MIP-1α-positive CD8＋ T-cells were significantly higher in 
patients with DHF [7.21 (5.36∼10.81) vs. 3.04 (1.75∼ 
4.02); p=0.011 and 6.2% (3.2∼8.2%) vs. 2.4% (2.0∼3.6%); 
p=0.023]. The latter showed a significant positive correla-
tion with IFN-γ/IL-4 ratio in CD4＋ T-cells (Spearman’s 
rho=0.64; p=0.003), percentage-change in haematocrit 
(rho=0.47; p=0.048), and serum alanine aminotransferase 
level (rho=0.61; p=0.009). Conclusion: We conclude that 
DHF is associated with a TH1-skewed immune response. 
Further, MIP-1α in CD8＋ T-cells is an important immuno-
logic correlate of disease severity in dengue.
[Immune Network 2010;10(5):164-172]
INTRODUCTION
Dengue virus infection is the most common arthropod-borne 
viral infection worldwide (1). Most instances of dengue virus 
i n f e c t i o n  a r e  a s y m p t o m a t i c  o r  r e s u l t  i n  a  s h o r t - l a s t i n g  u n -
differentiated febrile illness, especially in children (2). Symp-
tomatic dengue virus infection often results in a characteristic 
self-limited illness described as classical dengue fever (DF). 
Dengue haemorrhagic fever (DHF) is an infrequent but po-
tentially lethal form of illness that develops usually following 
secondary infection with a heterologous serotype of dengue 
virus (1). The hallmark of DHF is the occurrence of plasma 
leakage  (3).  Although  it  is  widely  accepted  that  im-
munopathology  underlies  the  development  of  plasma  leak-
age, the pathogenesis of DHF is incompletely understood (3). 
Higher plasma viraemia early in the course of infection and 
consequent T-cell activation are known to predispose to the 
development  of  DHF  (4,5).  Macrophage  inflammatory  pro-
tein-1α (MIP-1α)  is  a  chemokine  that  plays  an  important 
role in the immunopathogenesis of viral infections. Recent in 
vitro st ud ie s h av e su g g e st ed  a pat h og e n ic  r ol e fo r M I P- 1α 
in  dengue  virus  infection  as  well  (6).
    Earlier, we have reported the occurrence of a TH2-skewed 
immune  response  around  the  time  of  defervescence  in  a 
group  of  patients  comprising  mostly  of  those  with  DF  (7). 
We noted a trend towards a higher intracellular interferon-γ 
(IFN-γ)/interleukin-4 (IL-4) ratio and lower serum IgE levels 
in patients with DHF as compared to those with DF. Based TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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on  these  preliminary  findings,  we  postulated  that  an  un-
opposed TH1 type immune response contributes to the patho-
genesis of DHF (7). In the present study, we tested this hy-
po t he si s in  a l arg e r g r ou p o f p at ie nt s w it h  va ry in g  se ve ri ty 
of dengue. In addition, we also attempted to define the role 
of MIP-1α as an immunologic correlate of disease severity 
in  patients  with  dengue.
MATERIALS AND METHODS
Subjects
This study was conducted at the All India Institute of Medical 
Sciences hospital, New Delhi, India. This is a large tertiary 
level teaching hospital located in northern India. In this part 
of the world dengue transmission is largely seasonal, punc-
tuated by several epidemics in the past, the most recent one 
being in the year 2003. An outbreak of dengue occurred in 
New Delhi during the months of October-November 2006 re-
s u l t i n g  i n  a b o u t  3 , 3 0 0  c a s e s  a n d  6 5  d e a t h s  ( 8 ) .  W e  p r o -
spectively enrolled patients aged more than 12 years with se-
rologically confirmed dengue virus infection hospitalised dur-
ing this outbreak. In order to circumvent the uncertainty re-
garding the classification of disease severity using the current 
World Health Organization (WHO) definitions (9) and to elu-
cidate  clearly  the  differences  in  immune  response  between 
patients with DF and DHF, we employed a purposive sam-
pling strategy - patients with DHF recruited in the study had 
unequivocal  features  of  plasma  leakage  evidenced  by  the 
presence  of  haemoconcentration  along  with  serosal  effu-
s i o n ( s ) ,  a n d  t h o s e  i n  t h e  D F  g r o u p  h a d  n o n e  o f  t h e s e  
features.  We  graded  the  severity  of  DHF  as  per  the  WHO 
classification  (10).  None  of  the  patients  were  atopic  or  re-
ported  any  risk  factor  for  human  immunodeficiency  virus 
infection. We also screened 20 healthy, non-atopic volunteers 
with no history of DF/DHF in the past for the presence of 
dengue-specific serum IgG and IgM antibodies. After screen-
ing,  we  chose  10  dengue-naive  volunteers  (five  males)  as 
controls for immunological studies. The study was conducted 
in compliance with the ethical guidelines for biomedical re-
search  on  human  subjects,  Indian  Council  of  Medical 
Research, New Delhi, India. We obtained informed consent 
from  all  study  patients/volunteers  or  their  legal  guardians.
    We prospectively collected data on demographic character-
istics, clinical findings, and laboratory findings such as serial 
haematocrit and platelet counts, total and differential leuko-
cyte  counts,  and  liver  function  tests  using  a  predesigned 
instrument. Dengue viral RNA detection and serotype identi-
fication was done by a reverse transcriptase polymerase chain 
reaction (RT-PCR) assay, as described earlier (11). Dengue- 
specific IgM and IgG antibodies in the serum were estimated 
using  commercially  available  capture  enzyme-linked  im-
munosorbent assay kits (Panbio Ltd., Queensland, Australia). 
After initial fluid resuscitation and stabilization, we collected 
peripheral venous blood specimens for immunological studies 
(baseline specimen), and repeated the immunological studies 
after 48 h and on day 5 of hospitalisation. In order to account 
for the diurnal rhythm in TH1-TH2 balance, we collected the 
blood  specimens  for  immunological  studies  in  the  morning 
at approximately the same time within a time window of 2 h.
Immunological studies
Peripheral blood mononuclear cells (PBMCs) were isolated by 
Ficoll-Hypaque density gradient centrifugation, washed twice, 
and resuspended in RPMI 1640 cell culture medium supple-
mented  with  10%  inactivated  foetal  bovine  serum.  PBMCs 
were stimulated with phorbol myristate acetate (1 ng/ml) and 
ionomycin (1μM) in the presence of the Golgi transport in-
hibitor,  monensin  (2μM),  for  6  h  in  a  humidified  5%  CO2 
incubator  at  37
oC.  Following  stimulation,  the  PBMCs  were 
collected,  and  immunostaining  was  done  as  per  the  manu-
facturer’s  specifications  (BD  Pharmingen,  BD  Biosciences, 
San Diego, CA). Surface staining for CD8 was performed with 
Cy5PE-labelled monoclonal antibodies at 4
oC for 15 min. For 
intracellular immunostaining, stimulated PBMCs were fixed in 
2% formaldehyde and permeabilised with 0.5% saponin, fol-
lowed  by  staining  with  fluorescein  isothiocyanate-labelled 
IL-4 and tumor necrosis factor-α (TNF-α) monoclonal anti-
bodies and phycoerythrin-labelled IFN-γ and MIP-1α mono-
clonal  antibodies.  Samples  were  run  in  a  flow  cytometer 
(FACSCalibur,  BD  Biosciences,  CA)  within  24  h  of  staining 
and  analysed  using  FlowJo  cytometry  analysis  software. 
Serum samples were stored at −20
oC. Estimation of serum 
IFN-γ, IL-4, and TNF-α was performed in duplicate using 
commercially  available enzyme-linked immunosorbent assay 
kits (BD Biosciences, San Diego, CA). The lower limit of de-
tection  for  these  assays  was  2  pg/ml.
Statistical analysis
We performed all statistical analyses using a software package 
(SPSS for Windows, version 11.5, SPSS Inc., Chicago, IL). We 
present normally distributed continuous variables as mean± 
SD and compared them between the DF and DHF groups us-TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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Table I. Clinical characteristics of the 20 patients with dengue 
included in the study
Characteristic DHF (n=10) DF (n=10)
Age (years)*         32±8        27±10
Male gender (n)        10/10
†          4/10
†
Duration of fever (days)
‡    5.0 (3.3∼7.0)    4.0 (2.5∼6.5)
Spontaneous bleeding (n)         5/10          3/10
Haematocrit (%)*      47.4±5.5     39.7±8.7
Total lymphocyte    2,288±1,044
§   1,576±508
§
 count (cells/μl)*
Platelet count at 28.5 (14.8∼45.0)  25.0 (16.0∼47.0)
 admission (×10
3/μl)
‡
Pleural effusion (n)          8/10          0/10
Ascites (n)          9/10          0/10
Serum ALT (IU/L)
‡   186 (110∼588)
∥   115 (55∼133)
∥
DHF: dengue haemorrhagic fever, DF: dengue fever, ALT: 
alanine aminotransferase. *Data presented as mean±SD, 
†p= 
0.011 for DHF vs. DF, 
‡Data presented as median (IQR), 
§p= 
0.104 for DHF vs. DF, 
∥p=0.033 for DHF vs. DF.
ing independent t-test. We present continuous variables with 
a  skewed  distribution  as  median  (interquartile  range)  and 
compared them between the groups using Mann-Whitney U 
test. We compared serial observations within a group using 
a  nonparametric  equivalent  of  repeated  measures  ANOVA 
(Friedman test), and applied the Spearman’s rank correlation 
to test the correlation between two continuous variables. We 
applied the Cuzick test to test for a linear trend across the 
ordered groups, namely, controls vs. DF vs. DHF. We calcu-
lated percentage-change in haematocrit as [(haematocrithighest
−haematocritdischarge)/haematocritdischarge]. We present the cat-
egorical variables as number (%) of patients and compared 
them  between  groups  by  chi-squared  test.  In  addition,  we 
carried out stratified analyses to evaluate the effect of the fol-
lowing baseline characteristics - gender, duration of fever at 
presentation, and dengue virus serotype - on the IFN-γ/IL-4 
ratio in CD4＋ T-cells. All tests were two-sided, and p＜0.05 
was  considered  statistically  significant.
RESULTS
We studied 20 patients (DF=10, DHF=10) and 10 dengue-na-
ïve healthy controls. Mean age of the patients and controls 
was 29±9 and 23±3 years, respectively. Among the patients, 
the median duration of fever at the time of hospitalisation was 
5 (3∼7) days. Of the 10 patients with DHF, four had grade 
I, five had grade II, and the remaining one patient had grade 
III DHF. All patients except the one that had grade III DHF 
recovered from the illness uneventfully and survived to hospi-
tal  discharge.  Based  on  the  dengue-specific  antibody  re-
sponses in the serum, all patients except one with DHF were 
characterized as secondary dengue virus infections. Dengue 
viral RNA was detected by RT-PCR in 10 of 20 patients tested 
- serotype 3 (DENV3) in four and serotype 4 (DENV4) in six 
patients respectively; of these 10 patients, eight had DF (four 
each of DENV3 and DENV4) and the remaining two patients 
with DENV4 infection had DHF. Age, duration of fever at pre-
sentation, and platelet count at admission were comparable 
between patients in the DF and DHF groups (Table I). All 
patients in the DHF group were male as compared to the DF 
group  in  which  males  comprised  only  about  a  half  of  the 
group. Serum alanine aminotransferase (ALT) levels were sig-
n i f i c a n t l y  h i g h e r  i n  t h e  D H F  g r o u p  ( T a b l e  I ) .
    As compared to dengue-naïve controls, the proportion of 
IFN-γ-positive CD4＋ T-cells as well as CD8＋ T-cells was 
markedly higher at baseline in both DF and DHF groups, and 
an  increasing  trend  was  observed  across  the  three  groups 
namely, controls vs. DF vs. DHF (p＜0.001 for both trends; 
Table II, Fig. 1). Similarly, an increasing trend across these 
groups was also noted in the proportion of MIP-1α-positive 
CD8＋ as well as CD4＋ T-cells (p＜0.001 for both) and the 
IFN-γ/IL-4 ratio in the CD4＋ as well as the CD8＋ T-cell 
compartments (p＜0.001 and p=0.004, respectively; Fig. 2). 
Interestingly,  IL-4-positive  CD4＋ T-cells  were  significantly 
higher in the DF group (p=0.023), but not in the DHF group 
(p=0.912),  as  compared  to  controls  (Table  II).
  As compared to DF, in patients with DHF the proportion 
of CD4＋ T-cells positive for intracellular IFN-γ was higher 
at baseline and those positive for IL-4 was lower (Table II), 
resulting in a significantly higher IFN-γ/IL-4 ratio in the CD4
＋ T-cell compartment [7.21 (5.36∼10.81) vs. 3.04 (1.75∼
4.02); Fig. 1; p=0.011]. Similarly, proportion of MIP-1α-posi-
tive CD8＋ T-cells was significantly higher in the DHF group 
(Table II; p=0.023). Further, there was a strong positive cor-
relation between IFN-γ/IL-4 ratio in the CD4＋ T-cell com-
partment and MIP-1α in CD8＋ T-cells (Fig. 3A; Spearman’s 
rho=0.64;  p=0.003).  Proportion  of  MIP-1α-positive  CD8＋ 
T-cells also had a significant positive correlation with the per-
c e n t a g e - c h a n g e  i n  t h e  h a e m a t o c r i t  ( F i g .  3 B ;  S p e a r m a n ’s 
rho=0.47; p=0.048) and with serum levels of ALT (Fig. 3C; 
Spearman’s rho=0.61; p=0.009). However, it did not correlate 
with platelet count nadir, absolute neutrophil count, and total 
lymphocyte  count  (data  not  shown).TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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Figure 1. Representative Flowcy-
tometry Plots: Flow cytometry 
plots showing CD8 positive cyto-
kine and chemokine producing T 
cells in DHF/DSS (Dengue hemor-
rhagic fever/Dengue shock synd-
rome), DF (Dengue fever) along 
with DN-H (Dengue negative 
healthy) individuals peripheral 
blood. X-axis of the graph shows 
CD8＋  T cells and Y axis has 
cytokine and chemokines as mea-
sured  in vitro on polyclonal 
stimulation.
Figure 2. A group-wise plot of the ratio of interferon-γ- (IFN-γ) positive to interleukin-4- (IL-4) positive CD4＋ T-cells (A) and CD8＋ T-cells 
(B) in dengue-naïve healthy controls (controls), patients with dengue fever (DF), and dengue haemorrhagic fever (DHF); horizontal lines across
the data points depict the group median; a non-parametric test (Cuzick test) was applied to test for a linear trend across the three groups.TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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Figure 3. Scatter plots of percentage of MIP-1α-positive CD8＋ T-cells
against IFN-γ/IL-4 ratio in CD4＋ T-cells (A), percentage-change in 
haematocrit (B), and serum alanine aminotransferase level (C); Gray 
lines represent the linear regression lines.
Figure 4. A plot of the IFN-γ/IL-4 ratio at baseline in CD4＋ T-cells 
against the duration of fever at enrollment. Closed triangles (▲) depict
dengue fever and the closed squares (■) depict dengue haemorrhagic
fever.
    On stratified analysis, when the analysis was restricted to 
males, IFN-γ/IL-4 ratio in the CD4＋ T-cell compartment re-
mained comparatively higher in patients with DHF [7.21 (5.36
∼10.81)  vs.  2.86  (2.00∼5.55)].  When  individually  plotted 
according to the duration of fever at presentation, the IFN-γ/ 
IL-4  ratio  in  CD4＋ T-cells  was  higher  in  all  patients  with 
DHF except one as compared to patients with DF of the same 
duration of fever (Fig. 4). The IFN-γ/IL-4 ratio in the CD4＋ 
T-cell compartment was similar between patients with DENV3 
and DENV4 infections in the DF group [2.87 (1.80∼5.58) vs. 
2.36  (1.61∼5.47)].
  On serial estimation (Table II), in patients with DF, there 
was a significant decline in the proportion of IFN-γ-positive 
CD8＋ T-cells (p=0.021) and a trend towards an increase in 
TNF-α-positive  CD8＋ T-cells  (p=0.066).  Further,  in  this 
group, a declining trend was observed in the proportion of TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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IL-4-positive CD4＋ T-cells (p=0.066), while IFN-γ-positive 
CD4＋ T-cells and MIP-1α-positive CD8＋ T-cells showed no 
significant change over time. In patients with DHF, there was 
a significant decline in the proportion of IFN-γ-positive CD8＋ 
T-cells  (p=0.005),  as  observed  in  the  other  group  (Fig.  4).
    In  the  serum,  at  baseline,  measurable  quantities  of  IL-4 
were found in 4 of 10 patients in the DF group, while it was 
undetectable despite repeated estimations in all patients with 
DHF. Importantly, a conspicuous discordance between serum 
and intracellular IFN-γ was noted in patients with DHF - se-
rum IFN-γ levels were comparatively lower in patients with 
DHF as compared to DF at all time points of the study despite 
higher IFN-γ in the T-cell compartments (Table II). A declin-
ing trend on serial estimation was observed in the serum lev-
els  of  TNF-α in  patients  with  DHF  (p=0.075).
DISCUSSION
    We found that the intracellular IFN-γ/IL-4 ratio in CD4＋ 
T-cells was significantly higher in patients with DHF, suggest-
ing  a  TH1-skewed  immune  response  in  these  patients.  The 
present study extends our earlier findings and confirms the 
hypothesis that DHF is associated with a TH1-skewed immune 
r e s p o n s e  a r o u n d  t h e  t i m e  o f  d e f e r v e s c e n c e  v i s  a  v i s  a  
TH2-skewed response in patients with DF. We also found that 
MIP-1α in  CD8＋ T-cells  positively  correlated  with  certain 
important  markers  of  disease  severity  such  as  percentage- 
change in haematocrit and serum ALT levels. These markers 
are directly reflective of two important events in the patho-
genesis of DHF namely vascular leakage and hepatocyte in-
jury,  respectively  (1,12).  MIP-1α i s  a  C C  c h e m o k i n e  w i t h  
pro-inflammatory  and  stem  cell  inhibitory  activities  in  vitro 
and is known to mediate virus-induced inflammation in vivo 
(13). Correlation of MIP-1α with the markers of disease se-
verity suggests that the former might be an important media-
tor of immunopathology in DHF. To the best of our knowl-
edge, the association between MIP-1α and disease severity 
in  patients  with  dengue  has  not  been  reported  earlier,  al-
though it has been hypothesised based on in vitro findings 
(6). It has also been suggested that MIP-1α might be respon-
sible for the transient bone marrow suppression seen in pa-
tients with dengue (14). We, however, did not observe any 
significant association between MIP-1α and the parameters 
reflective of bone marrow suppression in the present study.
    There are at least four potential confounding variables that 
could account for a higher IFN-γ/IL-4 ratio in patients with 
DHF - i) primary vs. secondary immune response; ii) duration 
of fever at presentation; iii) gender; and iv) differences in in-
fecting  serotype.  Serendipitously,  all  but  one  patients  in-
cluded  in  the  present  study  had  secondary  dengue  virus 
infection. This negates confounding by the first of these four 
variables, and stratified analyses do not suggest the presence 
of confounding by any of the remaining three variables. Thus, 
we consider that the observed difference was in fact attribut-
able  to  difference  in  disease  severity.
    There are at least two potential explanations for this ob-
served  association  of  a  TH1-skewed  immune  response  with 
DHF. First, antibody-dependent enhancement of dengue virus 
infection is a key mechanism thought to underlie the patho-
genesis of DHF (15). IFN-γ is known to enhance the Fcγ 
receptor-mediated infection of monocytic cells by the dengue 
virus bound to cross-reactive antibodies (16); elevated levels 
of IFN-γ production by TH1-polarised T-cells would thus re-
sult in an increased infected cell mass. Second, TH1-polarised 
cytokine(s)  enhances  presentation  of  viral  epitopes  by  pro-
fessional antigen presenting cells to CD8＋ T-cells, leading to 
their  activation  (17).  CD8＋ cytotoxic  T-cells  play  an  im-
portant role in viral clearance and immunopathology of den-
gue  virus  infection  (18,19).
    On  the  other  hand,  activated  CD8＋ T-cells  are  a  bio-
logically important source of MIP-1α in intracellular infection 
models (20), and MIP-1α is known to skew the immune re-
sponse towards a TH1 polarity (21). Thus, the positive correla-
tion between IFN-γ/IL-4 ratio in CD4＋ T-cells and MIP-1α 
in CD8＋ T-cells, observed in the current study, is probably 
the result of a bidirectional positive feedback loop operating 
between these two compartments. Earlier studies have estab-
lished the association of early immune activation (in quantita-
tive terms) with the subsequent development of DHF in pa-
tients with dengue virus infection (Green S et al., 1999). In 
the  present  study,  we  have  characterised  this  immune  re-
sponse  as  a  TH1-skewed  response  at  the  intracellular  level. 
In  a  well-conducted  study  by  Green  et  al.  (5),  it  was  ob-
served  that  the  plasma  IFN-γ levels  abruptly  increased  in 
children with DHF just preceding the defervescence of fever 
followed by a decline. The findings of the present study sug-
gest  the  occurrence  of  a  similar  phenomenon  at  the  intra-
cellular level as well. The current understanding of the patho-
genesis  of  DHF  is  far  from  complete  and  controversial. 
Though an oversimplification, it is generally agreed that the 
positive feedback of IFN-γ secreted by activated T-cells on 
macrophages sets off a vicious cycle of dysregulated cytokine TH1-TH2 Balance, MIP-1α, and Disease Severity in Dengue
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production leading to DHF. A TH1-skewed immune response 
in patients with DHF as found in the present study is in con-
sonance  with  this  concept.
    Notwithstanding, another school of thought holds that DHF 
is associated with a T H2 type immune response (22,23). There 
are several important limitations that could have biased the 
findings  of  these  studies  -  first,  the  patients  were  classified 
as DF or DHF based on assessment at the time of enrollment 
(24). Subsequent clinical progression to DHF of patients ini-
tially classified as DF, which is a common phenomenon, was 
not taken into account, and this could have resulted in mis-
classification of cases. Second, the uncertainty in classification 
of disease severity using the WHO definitions (9) could also 
have  contributed  to  misclassification  of  patients  to  an  un-
known extent in these studies. We circumvented these biases 
by  adopting  a  purposive  sampling  strategy.  Third,  the  in-
creased vascular permeability in DHF is likely to cause a leak-
age of secreted cytokines into the extravascular space result-
ing  in  a  discordance  of  serum  levels  with  the  actual  intra-
c e l l u l a r  e x p r e s s i o n  o f  c y t o k ines -  we  found  suggestive evi-
dence for the existence of such discordance  in  the present 
study.  If  one  estimates  only  the  serum  levels  of  cytokines 
(24), it would paradoxically appear that the very same cyto-
kines  associated  with  DHF  are  comparatively  lower  in  the 
sera  of  patients  with  DHF  as  compared  to  DF.  This  could 
explain  the  fact  why  earlier  studies  that  estimated  cytokine 
l e v e l s  o n l y  i n  t h e  s e r u m  o f  p a t i e n t s  w i t h  D H F  f o u n d  a  
TH2-skewed pattern even though at the intracellular level the 
T-cell  response  is  actually  TH1-skewed  in  nature.
    Cell-mediated immunity is a very important mechanism by 
which  the  host  clears  off  an  established  viral  infection.  An 
exuberant cell-mediated immune response also clears the vi-
ral  infection  albeit  at  the  cost  of  considerable  immunopa-
thology. Despite the lack of any specific anti-viral treatment, 
the mortality in patients with DHF has been brought down 
to less than 1% with supportive management alone (25); this 
implies that the immune response alone manages to success-
fully  clear  off  the  viraemia  in  all  these  patients.  If  DHF  is 
characterised  by  a  TH2-skewed  immune  response,  as  pro-
posed  by  some  authors,  it  cannot  explain  this  observation. 
Further ancillary evidence to our finding that DHF is charac-
terised by a TH1-skewed immune response comes from the 
epidemiologic observation that malnutrition decreases the risk 
of DHF in patients with dengue virus infection (26). Malnutri-
tion is known to impair the cell-mediated immune response 
r e s u l t i n g  i n  a  s h i f t  t o w a r d s  a  T H2  p r o f i l e  ( 2 7 ) .  T h o u g h  t h e 
present  study  brings  out  the  association  between  a  TH1- 
skewed immune response and DHF, it does not tell us exactly 
which  factor  tipped  off  the  balance  towards  a  TH1-skewed 
CD4＋ T-cell response. We believe the missing link could be 
the expansion of regulatory T-cells in patients with milder dis-
ease  which suppresses  the  IFN-γ production  (28)  possibly 
skewing the immune response towards a TH2 profile in DF.
    To conclude, we found that the intracellular IFN-γ/IL-4 ra-
tio in CD4＋ T-cells and MIP-1α in CD8＋ T-cells were sig-
nificantly higher in patients with DHF. We also observed that 
MIP-1α in CD8＋ T-cells positively correlated with the intra-
cellular  IFN-γ/IL-4  ratio  in  CD4＋ T-cells  as  well  as  im-
portant markers of disease severity in patients with dengue 
virus infection. These findings confirm our hypothesis that an 
unopposed TH1 immune response underlies the pathogenesis 
of DHF. The present findings also suggest that MIP-1α might 
be  an  important  mediator  of  immunopathology  in  DHF.
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